Uploaded December 2025 | Updated November 2026, 8 hours ago
Presented By: Amanda Grimm, B.S., PSM
Speaker Biography: Amanda is an experienced life sciences professional specializing in in vitro diagnostics and antibody drug development. With a background in immunopathology research, immunoassay development, and product management, she brings both scientific and commercial expertise to her role.
At GenScript, Amanda leads marketing strategy and portfolio education to support researchers in their development of novel in vitro diagnostics and antibody drug discovery. She holds dual Bachelor of Science degrees in Microbiology and Biochemistry and a Professional Science Master’s (PSM) from Washington State University.
Webinar: From Insight to Impact: Enabling Sensitive, Specific POC Assays for Infectious Disease
Webinar Abstract: Many assays still fall short in the effort to detect infectious diseases more rapidly and at the point of care. The challenge is not a lack of innovation, but rather unseen gaps in reagent quality, specificity, and reproducibility. Imagine being able to detect low-abundance pathogens, avoid cross-reactivity, and ensure consistency across batches from early discovery through scale-up.
This webinar will explore the common but often overlooked hurdles in developing sensitive and specific point-of-care diagnostics for respiratory viruses, antimicrobial-resistant bacteria, and complex microbial environments. We will highlight how precision-engineered antigens, antibodies, and molecular tools can improve signal detection, reduce background noise, and accelerate development timelines.
Through published examples and overview of the GenScript’s portfolio of IVD solutions, which include custom monoclonal antibodies, recombinant antigens, CRISPR enzymes, and NGS-ready oligos, participants will see how high-quality reagents combined with biological insight can lead to meaningful diagnostic advances. Whether you are working on lateral flow assays, ELISAs, or molecular tests, you will gain strategies to bring greater precision to every stage of assay development.
Labroots on Social:
Facebook: facebook.com/LabRootsInc
Twitter: twitter.com/LabRoots
LinkedIn: linkedin.com/company/labroots
Instagram: instagram.com/labrootsinc
Pinterest: pinterest.com/labroots
SnapChat: labroots_inc
Presented By: Amanda Grimm, B.S., PSM
Speaker Biography: Amanda is an experienced life sciences professional specializing in in vitro diagnostics and antibody drug development. With a background in immunopathology research, immunoassay development, and product management, she brings both scientific and commercial expertise to her role.
At GenScript, Amanda leads marketing strategy and portfolio education to support researchers in their development of novel in vitro diagnostics and antibody drug discovery. She holds dual Bachelor of Science degrees in Microbiology and Biochemistry and a Professional Science Master’s (PSM) from Washington State University.
Webinar: From Insight to Impact: Enabling Sensitive, Specific POC Assays for Infectious Disease
Webinar Abstract: Many assays still fall short in the effort to detect infectious diseases more rapidly and at the point of care. The challenge is not a lack of innovation, but rather unseen gaps in reagent quality, specificity, and reproducibility. Imagine being able to detect low-abundance pathogens, avoid cross-reactivity, and ensure consistency across batches from early discovery through scale-up.
This webinar will explore the common but often overlooked hurdles in developing sensitive and specific point-of-care diagnostics for respiratory viruses, antimicrobial-resistant bacteria, and complex microbial environments. We will highlight how precision-engineered antigens, antibodies, and molecular tools can improve signal detection, reduce background noise, and accelerate development timelines.
Through published examples and overview of the GenScript’s portfolio of IVD solutions, which include custom monoclonal antibodies, recombinant antigens, CRISPR enzymes, and NGS-ready oligos, participants will see how high-quality reagents combined with biological insight can lead to meaningful diagnostic advances. Whether you are working on lateral flow assays, ELISAs, or molecular tests, you will gain strategies to bring greater precision to every stage of assay development.
Labroots on Social:
Facebook: facebook.com/LabRootsInc
Twitter: twitter.com/LabRoots
LinkedIn: linkedin.com/company/labroots
Instagram: instagram.com/labrootsinc
Pinterest: pinterest.com/labroots
SnapChat: labroots_inc




